Literature DB >> 10556937

Effects of luteolin and quercetin, inhibitors of tyrosine kinase, on cell growth and metastasis-associated properties in A431 cells overexpressing epidermal growth factor receptor.

Y T Huang1, J J Hwang, P P Lee, F C Ke, J H Huang, C J Huang, C Kandaswami, E Middleton, M T Lee.   

Abstract

1. Flavonoids display a wide range of pharmacological properties including anti-inflammatory. Anti-mutagenic, anti-carcinogenic and anti-cancer effects. Here, we evaluated the effects of eight flavonoids on the tumour cell proliferation, cellular protein phosphorylation, and matrix metalloproteinase (MMPs) secretion. 2. Of the flavonoids examined, luteolin (Lu) and quercetin (Qu) were the two most potent agents, and significantly inhibited A431 cell proliferation with IC50 values of 19 and 21 micronM, respectively. 3. The epidermal growth factor (EGF) (10 nM) promoted growth of A431 cells (+25+/-4.6%) and mediated epidermal growth factor receptor (EGFR) tyrosine kinase activity and autophosphorylation of EGFR were inhibited by Lu and Qu. At concentration of 20 micronM, both Lu and Qu markedly decreased the levels of phosphorylation of A431 cellular proteins, including EGFR. 4. A431 cells treated with Lu or Qu exhibited protuberant cytoplasmic blebs and progressive shrinkage morphology. Lu and Qu also time-dependently induced the appearance of a ladder pattern of DNA fragmentation, and this effect was abolished by EGF treatment. 5. The addition of EGF only marginally diminished the inhibitory effect of luteolin and quercetin on the growth rate of A431 cells, treatment of cellular proteins with EGF and luteolin or quercetin greatly reduced protein phosphorylation, indicating Lu and Qu may act effectively to inhibit a wide range of protein kinases, including EGFR tyrosine kinase. 6. EGF increased the levels of matrix metalloproteinase-2 (MMP-2) and matrix metalloproteinase-9 (MMP-9), while Lu and Qu appeared to suppress the secretion of these two MMPs in A431 cells. 7. Examination of the relationship between the chemical structure and inhibitory effects of eight flavonoids reveal that the double bond between C2 and C3 in ring C and the OH groups on C3' and C4' in ring B are critical for the biological activities. 8. This study demonstrates that the inhibitory effects of Lu and Qu, and the stimulatory effects of EGF, on tumour cell proliferation, cellular protein phosphorylation, and MMP secretion may be mediated at least partly through EGFR. This study supports the idea that Lu and Qu may have potential as anti-cancer and anti-metastasis agents.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10556937      PMCID: PMC1571723          DOI: 10.1038/sj.bjp.0702879

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  60 in total

1.  Structure-antioxidant activity relationships of flavonoids and phenolic acids.

Authors:  C A Rice-Evans; N J Miller; G Paganga
Journal:  Free Radic Biol Med       Date:  1996       Impact factor: 7.376

Review 2.  Protein tyrosine kinases and cancer.

Authors:  K S Kolibaba; B J Druker
Journal:  Biochim Biophys Acta       Date:  1997-12-09

3.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 5.  The flavonoids. A class of semi-essential food components: their role in human nutrition.

Authors:  J Kühnau
Journal:  World Rev Nutr Diet       Date:  1976       Impact factor: 0.575

6.  The effect of flavonoids on aerobic glycolysis and growth of tumor cells.

Authors:  E M Suolinna; R N Buchsbaum; E Racker
Journal:  Cancer Res       Date:  1975-07       Impact factor: 12.701

7.  Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: a comparison with tyrosine kinase and protein kinase C inhibition.

Authors:  G Agullo; L Gamet-Payrastre; S Manenti; C Viala; C Rémésy; H Chap; B Payrastre
Journal:  Biochem Pharmacol       Date:  1997-06-01       Impact factor: 5.858

8.  Expression of angiogenesis-related genes and progression of human ovarian carcinomas in nude mice.

Authors:  J Yoneda; H Kuniyasu; M A Crispens; J E Price; C D Bucana; I J Fidler
Journal:  J Natl Cancer Inst       Date:  1998-03-18       Impact factor: 13.506

9.  Matrix metalloprotease 2 (MMP-2) and matrix metalloprotease 9 (MMP-9) type IV collagenases in colorectal cancer.

Authors:  N B Liabakk; I Talbot; R A Smith; K Wilkinson; F Balkwill
Journal:  Cancer Res       Date:  1996-01-01       Impact factor: 12.701

10.  Tyrosine kinase inhibitors, emodin and its derivative repress HER-2/neu-induced cellular transformation and metastasis-associated properties.

Authors:  L Zhang; Y K Lau; L Xi; R L Hong; D S Kim; C F Chen; G N Hortobagyi; C Chang; M C Hung
Journal:  Oncogene       Date:  1998-06-04       Impact factor: 9.867

View more
  44 in total

1.  Quercetin blocks airway epithelial cell chemokine expression.

Authors:  Suparna Nanua; Suzanna M Zick; Juan E Andrade; Umadevi S Sajjan; John R Burgess; Nicholas W Lukacs; Marc B Hershenson
Journal:  Am J Respir Cell Mol Biol       Date:  2006-06-22       Impact factor: 6.914

2.  Whole blueberry powder modulates the growth and metastasis of MDA-MB-231 triple negative breast tumors in nude mice.

Authors:  Lynn S Adams; Noriko Kanaya; Sheryl Phung; Zheng Liu; Shiuan Chen
Journal:  J Nutr       Date:  2011-08-31       Impact factor: 4.798

3.  Quercetin downregulates matrix metalloproteinases 2 and 9 proteins expression in prostate cancer cells (PC-3).

Authors:  M R Vijayababu; A Arunkumar; P Kanagaraj; P Venkataraman; G Krishnamoorthy; J Arunakaran
Journal:  Mol Cell Biochem       Date:  2006-04-28       Impact factor: 3.396

4.  Luteolin and sorafenib combination kills human hepatocellular carcinoma cells through apoptosis potentiation and JNK activation.

Authors:  Xu-Qin Feng; Li-Wen Rong; Rui-Xue Wang; Xue-Lian Zheng; Lei Zhang; Lin Zhang; Yong Lin; Xia Wang; Zhi-Ping Li
Journal:  Oncol Lett       Date:  2018-05-04       Impact factor: 2.967

Review 5.  Luteolin, a flavonoid with potential for cancer prevention and therapy.

Authors:  Yong Lin; Ranxin Shi; Xia Wang; Han-Ming Shen
Journal:  Curr Cancer Drug Targets       Date:  2008-11       Impact factor: 3.428

6.  Unnatural polyketide analogues selectively target the HER signaling pathway in human breast cancer cells.

Authors:  Seok Joon Kwon; Moon Il Kim; Bosung Ku; Lydie Coulombel; Jin-Hwan Kim; Joseph H Shawky; Robert J Linhardt; Jonathan S Dordick
Journal:  Chembiochem       Date:  2010-03-01       Impact factor: 3.164

7.  Ethyl acetate extracts of alfalfa (Medicago sativa L.) sprouts inhibit lipopolysaccharide-induced inflammation in vitro and in vivo.

Authors:  Yong-Han Hong; Wen-Wan Chao; Miaw-Ling Chen; Bi-Fong Lin
Journal:  J Biomed Sci       Date:  2009-07-14       Impact factor: 8.410

8.  Quercetin prevents progression of disease in elastase/LPS-exposed mice by negatively regulating MMP expression.

Authors:  Shyamala Ganesan; Andrea N Faris; Adam T Comstock; Sangbrita S Chattoraj; Asamanja Chattoraj; John R Burgess; Jeffrey L Curtis; Fernando J Martinez; Suzanna Zick; Marc B Hershenson; Uma S Sajjan
Journal:  Respir Res       Date:  2010-09-28

Review 9.  Are Polyphenols Strong Dietary Agents Against Neurotoxicity and Neurodegeneration?

Authors:  Susana Almeida; Marco G Alves; Mário Sousa; Pedro F Oliveira; Branca M Silva
Journal:  Neurotox Res       Date:  2016-01-08       Impact factor: 3.911

10.  Immunomodulatory responses of peripheral blood mononuclear cells from multiple sclerosis patients upon in vitro incubation with the flavonoid luteolin: additive effects of IFN-beta.

Authors:  Zohara Sternberg; Kailash Chadha; Alicia Lieberman; Allison Drake; David Hojnacki; Bianca Weinstock-Guttman; Frederick Munschauer
Journal:  J Neuroinflammation       Date:  2009-10-13       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.